Susquehanna International Group, LLP Next Cure, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	BUY	$1.13 - $2.23 $11,864 - $23,415	10,500 New	10,500 $23,000
Q3 2023 Nov 14, 2023	SELL	$1.29 - $1.84 $26,058 - $37,168	-20,200 Reduced 42.89%	26,900 $34,000
Q2 2023 Aug 11, 2023	BUY	$1.47 - $1.86 $50,127 - $63,426	34,100 Added 262.31%	47,100 $84,000
Q1 2023 May 16, 2023	BUY	$1.46 - $1.83 $18,980 - $23,790	13,000 New	13,000 $19,000
Q2 2022 Aug 15, 2022	BUY	$3.38 - $5.27 $476,918 - $743,596	141,100 Added 315.66%	185,800 $873,000
Q1 2022 May 16, 2022	SELL	$4.76 - $6.24 $179,452 - $235,248	-37,700 Reduced 45.75%	44,700 $217,000
Q4 2021 Feb 14, 2022	BUY	$5.7 - $9.1 $15,960 - $25,480	2,800 Added 3.52%	82,400 $494,000
Q3 2021 Nov 15, 2021	SELL	$6.74 - $8.02 $828,346 - $985,658	-122,900 Reduced 60.69%	79,600 $537,000
Q2 2021 Aug 11, 2021	BUY	$7.6 - $10.28 $832,960 - $1.13 Million	109,600 Added 117.98%	202,500 $1.63 Million
Q1 2021 May 17, 2021	SELL	$9.81 - $13.88 $667,080 - $943,840	-68,000 Reduced 42.26%	92,900 $930,000
Q4 2020 Feb 16, 2021	BUY	$9.47 - $12.43 $418,574 - $549,406	44,200 Added 37.87%	160,900 $1.75 Million
Q3 2020 Nov 16, 2020	BUY	$8.15 - $21.17 $951,105 - $2.47 Million	116,700 New	116,700 $1.03 Million

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $26.9M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.